News

12th May 2025

Aera Therapeutics Appoints Paul Conrad, Ph.D., MBA, as Chief Business and Financial Officer

16th February 2023

Aera Therapeutics Launches with $193 Million in Financing to Enable and Advance the Next Generation of Transformative Genetic Medicines

Top